Raj Vuppalanchi MD FAASLD

[Pronunciation: Vuppa Lanchi]

Hepatology & Liver Transplantation

Professor of Medicine

550 University BlvdSuite 1710Indianapolis, IN 46202
Phone+1 317-278-1652
Fax+1 317-278-1949

Dr. Vuppalanchi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vuppalanchi's full profile Already have an account?

Summary

Dr. Raj Vuppalanchi specializes in Gastroenterology with sub-specialties in Hepatology and Liver Transplantation, based in Indianapolis, Indiana. His educational background includes a Gastroenterology fellowship at Indiana University School of Medicine and an Internal Medicine residency at SUNY Health Science Center. He currently holds several positions, including a tenured professorship at Indiana University School of Medicine and a medical staff position at Eskenazi Health. Vuppalanchi’s expertise lies in a variety of liver conditions, including primary biliary cirrhosis, viral hepatitides, and non-alcoholic fatty liver disease. He has multiple publications under his belt and has actively participated in clinical trials for various liver conditions. His commendable work has also brought him several awards, including the Chancellors Teaching Award from Indiana University in 2017.

Education & Training

Indiana University School of MedicineFellowship, Gastroenterology, 2005 - 2007
Indiana Univ Sch Of Medicine Fellowship Clinical Pharmacology, 2003 - 2005
SUNY Downstate Health Sciences University/Long Island College HospitalResidency, Internal Medicine, 2000 - 2003
Gandhi Medical CollegeClass of 1998, MBBS
Little Flower Junior CollegeIntermediate, 1991

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IN State Medical License 2003 - 2027
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Chancellors Teaching Award Indiana University, 2017
CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2013-2017
CMS Meaningful Use Stage 1 Certification FirstNet and Cerner Healthe, Cerner Corporation, 2013-2017

Clinical Trials

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2019 Nov 19
COMPLETED
PHASE2
Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic Function Start of enrollment: 2020 Jul 16
COMPLETED
PHASE1

Publications & Presentations

PubMed

3 citations
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers ...
Suzanne Sharpton, Luis Antonio Díaz, Kay Pepin, Maral Amangurbanova, Egbert Madamba
Alimentary Pharmacology & Therapeutics. 2026-08-01
Molecular Eyes on the Bile Duct: Next-Generation Sequencing Earns Its Place in Biliary Stricture Evaluation.
Raj Vuppalanchi, Annika Bergquist
Gastroenterology. 2026-08-01
Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia.
Naga Chalasani, Ismael Alvarez-Alvarez, Paul H Hayashi, Raj Vuppalanchi, Marwan Ghabril
Clinical Pharmacology and Therapeutics. 2026-07-25

Journal Articles

Fecal Microbiota Transplantation for the Treatment of Recurrent and Severe Clostridium Difficile Infection in Solid Organ Transplant Recipients: A Multicenter Experience
Raj Vuppalanchi, Adam Ehrlich, Michael Smith, Asif Sharfuddin, Nasia Safdar, Nirmal Kaur, Elizabeth Ann Misch, Monika Fischer, Ann Flynn, Vincent Ganapini, Michael H W..., American Journal of Transplantation
Liver Stiffness Measurements in Patients with Non‐Cirrhotic Portal Hypertension – the Devil Is in the Details
Niharika Samala, Raj Vuppalanchi, Naga Chalasani, Hepatology
Isolated Melanosis of the Gastric Antrum.
Vuppalanchi R, Vakli S, Kahi C, An Unusual Endoscopic Finding;5(1):e2

Books/Book Chapters

Practical Hepatic Pathology: A Diagnostic Approach: A Volume in the Pattern Recognition Series.
Chapter: Metabolism of Drugs and Xenobiotics
Vuppalanchi RElsevierEdition 1st,
Practical Hepatic Pathology: A Diagnostic Approach: A Volume in the Pattern Recognition Series.
Chapter: Laboratory Tests in Liver Disease
Vuppalanchi R, Chalasani NElsevierEdition 1st,

Lectures

Drug-Induced Liver Injury: Causes and Management
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/6/2018
Liver Transplantation.
St,Vincent Hospital, Indianapolis, IN
Healthy You: Liver lessons.
American Liver Foundation, Indianapolis

Other

Serum biomarkers for diagnosis of non-alcoholic fatty liver disease.
Vuppalanchi R, US Provisional Patent Application No. 61/273,013

Press Mentions

Medical Bulletin 01/ July/ 2024June 30th, 2024
Galectin Therapeutics to Present Clinical Data at the Liver Meeting® 2017 Demonstrating the Ability of Non-Invasive Test to Identify Clinically Significant Portal Hypertension in Patients with Compensated NASH CirrhosisOctober 20th, 2017
miRNA Signatures Can Identify NASH Patients Needing TreatmentJune 5th, 2017